UNSPSC 51391712: Clenbuterol

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C12H18Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XTZ6AXU7KN, chemically known as 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol but generally known as clenbuterol, which bears US NIH Compound Identifier 2783. European Medicines Agency schedules Clenbuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06651MIG.

UNSPSC 51391712 Clenbuterol is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement activity. The two recent opportunities posted show no alignment with clenbuterol procurement; instead, they address naloxone distribution and pharmaceutical direct-contracting initiatives—neither of which is a clenbuterol application. The code shows little relevant recent activity.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the County Community Health Building and a due date of July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program serving state employee and retiree health plans outside traditional pharmacy benefit manager and group purchasing organization channels. Neither opportunity relates to the clenbuterol classification, suggesting a classification mismatch in the underlying state and local procurement database.